Company Celgene

Equities

CELG

Delayed Nasdaq 04:00:00 2019-11-20 pm EST 5-day change 1st Jan Change
108.2 USD +0.10% Intraday chart for Celgene -1.97% +68.89%

Business Summary

Celgene Corporation specializes in the design, development, and sale of products for treating cancer and immune system disorders. Net sales break down by product family as follows:

- therapeutic products (99.9%);

- other (0.1%): cellular therapy products and biological materials for implants, for tissue and organ treatments, and for therapeutic product development.

Net sales are distributed geographically as follows: the United States (65.6%), Europe (24.7%) and other (9.7%).

Managers

Managers TitleAgeSince
Director of Finance/CFO 55 18-06-30
President 53 19-11-19
Director/Board Member - 19-11-19
Director/Board Member 48 19-11-19
Investor Relations Contact - -
Corporate Officer/Principal 63 18-02-28
Treasurer - 19-11-19

Members of the board

Members of the board TitleAgeSince
President 53 19-11-19
Director/Board Member 48 19-11-19
Director/Board Member - 19-11-19

Company contact information

Celgene Corp.

86 Morris Avenue

07901, Summit

+908 673 9000

https://www.bms.com
address Celgene(CELG)

Group companies

NameCategory and Sector
Pharmaceuticals: Major
Celgene Logistics SARL
Celgene International II SARL
Seamair Insurance DAC

Sector

This company's sector is not yet available